Trellis Bioscience, Inc. Appoints John Wulf as EVP, Business Operations and Chief Business Officer

Published: Jan 04, 2008

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Trellis Bioscience, a privately held biotechnology company, today announced the appointment of John J. Wulf as Executive Vice President, Business Operations and Chief Business Officer. Mr. Wulf, a senior corporate development executive with over 20 years experience within the biotechnology industry, joins Trellis Bioscience from Y’s Therapeutics, where he was President, Chief Operating Officer and Chief Business Officer.

Back to news